Results 131 to 140 of about 32,129 (220)

Interaction between voriconazole and glimepiride

, 2010
Voriconazole, a triazole antifungal, is gaining popularity in the treatment of invasive fungal infections, mostly in the immuno-compromised patients. Voriconazole, a CYP2C9 inhibitor, has many potential drug interactions. Its interactions are both due to
Shobha, J. C., Muppidi, M. R.
core   +1 more source

Drug interactions with voriconazole

, 2015
Drug interactions are a potential problem with voriconazole therapy, due to the antifungal's extensive interaction with human cytochrome P450 enzymes and transporters.
VIALE, PIERLUIGI, LEWIS, RUSSEL EDWARD
core  

Clinical experience treating Paecilomyces lilacinus keratitis in four patients

Clinical Ophthalmology, 2012
Yu Monden,1 Minoru Sugita,1 Ryoji Yamakawa,1 Kazuko Nishimura,21Department of Ophthalmology, Kurume University School of Medicine, Kurume, Fukuoka, Japan; 2Medical Mycology Research Center, Chiba University and First Laboratories Co Ltd, Kawasaki ...
Monden Y, Sugita M, Yamakawa R, Nishimura K   +3 more
doaj  

Voriconazole

Drugs in R & D, 1999
openaire   +2 more sources

Therapeutic drug monitoring of voriconazole

, 2015
Invasive fungal diseases are associated with significant morbidity and mortality, especially in immunocompromised patients. Voriconazole is a first-line treatment for invasive aspergillosis, and an effective agent for candidiasis, fusariosis and ...
VIALE, PIERLUIGI, LEWIS, RUSSEL EDWARD
core  

Voriconazole therapy and CYP2C19 phenotype: identifying patients who may need alternative antifungal therapy. [PDF]

J Antimicrob Chemother
Wehbe E, Sreeharan T, Sutrave G, Bui J, Lau C, Park JY, Sandaradura I, Darley D, Macdonald P, Milliken S, Fung JN, Jones G, Kizny Gordon A, Kliman D, Lu CY, Marriott D, Alffenaar JC, Stocker SL.   +17 more
europepmc   +1 more source

Interpretation of Pharmacometabolomics Results: Fingerprint of Drug Exposure or Confounder Effects? Insights from a Urinary Metabolomics Study with Voriconazole in Healthy Participants. [PDF]

Int J Mol Sci
Chobanyan-Jürgens K, Muhareb A, Niesert M, Scherkl C, Meid AD, Cannet C, Pituk D, Hoffmann GF, Stingl JC, Ziegler A, Blank A.   +10 more
europepmc   +1 more source

Impact of Concomitant Metamizole Treatment on the Exposure of Mould-Active Triazoles. [PDF]

Mycoses
Vanneste D, De Booser I, Nadrah K, Somrak M, Gijsen M, Matos A, Kalan K, Morlion B, Rex S, Battelino S, Lagrou K, Maertens J, Spriet I.   +12 more
europepmc   +1 more source

Fatal cerebral scedosporiosis in a liver transplant recipient: Diagnostic pitfalls and antifungal resistance. [PDF]

Med Mycol Case Rep
Panda JP, Sunavala A, Narula S, Nagral A, Tandan S.   +4 more
europepmc   +1 more source

Time-varying voriconazole clearance during extracorporeal membrane oxygenation. [PDF]

Antimicrob Agents Chemother
Yusuff H, Gadsby J, Isgro G, Zochios V, Jenkins D, Cooke S, Mulla H.   +6 more
europepmc   +1 more source